Get it on Google Play

Lipella to present phase 2a trial results at investor forum

September 15, 2025 8:01 AM EDT Send to a Friend
Lipella Pharmaceuticals Inc. (OTC: LIPO) announced that Chief Executive Officer Jonathan Kaufman will present at the Zacks SCR Life Sciences ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login